Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
09/29

DJ Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. $(BMY)$ rose 1.62% to $63.88 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.77% to 7,683.69 and Dow Jones Industrial Average falling 0.67% to 51,481.51.

This was the stock's third consecutive day of gains.

Bristol Myers Squibb Co. closed 6.93% short of its 52-week high of $68.64, which the company reached on August 19th.

The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.27% to $271.95, Pfizer Inc. $(PFE)$ rose 0.17% to $28.72, and Abbott Laboratories $(ABT)$ fell 0.31% to $100.98.

Trading volume (13.4 M) eclipsed its 50-day average volume of 10.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 28, 2026.

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10